CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Saliva
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Breath
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market share analysis by country
CHAPTER 5: ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Drugs
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Alcohol
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Highway Police
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Drug Enforcement Agencies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
CHAPTER 7: ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Sample Type
7.2.3 North America Market size and forecast, by Substance
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Sample Type
7.2.5.1.3 Market size and forecast, by Substance
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Sample Type
7.2.5.2.3 Market size and forecast, by Substance
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Sample Type
7.2.5.3.3 Market size and forecast, by Substance
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Sample Type
7.3.3 Europe Market size and forecast, by Substance
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Sample Type
7.3.5.1.3 Market size and forecast, by Substance
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Sample Type
7.3.5.2.3 Market size and forecast, by Substance
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Sample Type
7.3.5.3.3 Market size and forecast, by Substance
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Sample Type
7.3.5.4.3 Market size and forecast, by Substance
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Sample Type
7.3.5.5.3 Market size and forecast, by Substance
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Sample Type
7.3.5.6.3 Market size and forecast, by Substance
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Sample Type
7.4.3 Asia-Pacific Market size and forecast, by Substance
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Sample Type
7.4.5.1.3 Market size and forecast, by Substance
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Sample Type
7.4.5.2.3 Market size and forecast, by Substance
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Sample Type
7.4.5.3.3 Market size and forecast, by Substance
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Sample Type
7.4.5.4.3 Market size and forecast, by Substance
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Sample Type
7.4.5.5.3 Market size and forecast, by Substance
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Sample Type
7.4.5.6.3 Market size and forecast, by Substance
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Sample Type
7.5.3 LAMEA Market size and forecast, by Substance
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Sample Type
7.5.5.1.3 Market size and forecast, by Substance
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Sample Type
7.5.5.2.3 Market size and forecast, by Substance
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Sample Type
7.5.5.3.3 Market size and forecast, by Substance
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Sample Type
7.5.5.4.3 Market size and forecast, by Substance
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 AK GlobalTech Corporation
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Alcohol Countermeasure Systems Corp.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Cannabix Technologies Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Dräger
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Intelligent Fingerprinting
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Lifeloc Technologies, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Oranoxis Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Thermo Fisher Scientific, Inc.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 UriTox LLC.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
TABLE 1. GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. ROADSIDE DRUG TESTING DEVICES MARKET FOR SALIVA, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. ROADSIDE DRUG TESTING DEVICES MARKET FOR SALIVA, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. ROADSIDE DRUG TESTING DEVICES MARKET FOR BREATH, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. ROADSIDE DRUG TESTING DEVICES MARKET FOR BREATH, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. ROADSIDE DRUG TESTING DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. ROADSIDE DRUG TESTING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 8. GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 9. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUGS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. ROADSIDE DRUG TESTING DEVICES MARKET FOR ALCOHOL, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. ROADSIDE DRUG TESTING DEVICES MARKET FOR ALCOHOL, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 13. GLOBAL ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 14. ROADSIDE DRUG TESTING DEVICES MARKET FOR HIGHWAY POLICE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 15. ROADSIDE DRUG TESTING DEVICES MARKET FOR HIGHWAY POLICE, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUG ENFORCEMENT AGENCIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. ROADSIDE DRUG TESTING DEVICES MARKET FOR DRUG ENFORCEMENT AGENCIES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. ROADSIDE DRUG TESTING DEVICES MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 23. U.S. ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. U.S. ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 26. CANADA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. CANADA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. MEXICO ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. MEXICO ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 32. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. GERMANY ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. GERMANY ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 39. FRANCE ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. FRANCE ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. UK ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. UK ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 45. ITALY ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. ITALY ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. SPAIN ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. SPAIN ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 51. REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 54. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 58. JAPAN ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. JAPAN ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 61. CHINA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. CHINA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 64. AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 66. AUSTRALIA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 67. INDIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. INDIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 69. INDIA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 70. SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 73. REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 76. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 80. BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 83. SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 89. REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SAMPLE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY SUBSTANCE, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA ROADSIDE DRUG TESTING DEVICES MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 92.ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 93.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 94.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 95.ABBOTT LABORATORIES: NET SALES
TABLE 96.ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 97.AK GLOBALTECH CORPORATION: COMPANY SNAPSHOT
TABLE 98.AK GLOBALTECH CORPORATION: OPERATING SEGMENTS
TABLE 99.AK GLOBALTECH CORPORATION: PRODUCT PORTFOLIO
TABLE 100.AK GLOBALTECH CORPORATION: NET SALES
TABLE 101.AK GLOBALTECH CORPORATION: KEY STRATERGIES
TABLE 102.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: COMPANY SNAPSHOT
TABLE 103.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: OPERATING SEGMENTS
TABLE 104.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: PRODUCT PORTFOLIO
TABLE 105.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: NET SALES
TABLE 106.ALCOHOL COUNTERMEASURE SYSTEMS CORP.: KEY STRATERGIES
TABLE 107.CANNABIX TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 108.CANNABIX TECHNOLOGIES INC.: OPERATING SEGMENTS
TABLE 109.CANNABIX TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 110.CANNABIX TECHNOLOGIES INC.: NET SALES
TABLE 111.CANNABIX TECHNOLOGIES INC.: KEY STRATERGIES
TABLE 112.DRÄGER: COMPANY SNAPSHOT
TABLE 113.DRÄGER: OPERATING SEGMENTS
TABLE 114.DRÄGER: PRODUCT PORTFOLIO
TABLE 115.DRÄGER: NET SALES
TABLE 116.DRÄGER: KEY STRATERGIES
TABLE 117.INTELLIGENT FINGERPRINTING: COMPANY SNAPSHOT
TABLE 118.INTELLIGENT FINGERPRINTING: OPERATING SEGMENTS
TABLE 119.INTELLIGENT FINGERPRINTING: PRODUCT PORTFOLIO
TABLE 120.INTELLIGENT FINGERPRINTING: NET SALES
TABLE 121.INTELLIGENT FINGERPRINTING: KEY STRATERGIES
TABLE 122.LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT
TABLE 123.LIFELOC TECHNOLOGIES, INC.: OPERATING SEGMENTS
TABLE 124.LIFELOC TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
TABLE 125.LIFELOC TECHNOLOGIES, INC.: NET SALES
TABLE 126.LIFELOC TECHNOLOGIES, INC.: KEY STRATERGIES
TABLE 127.ORANOXIS INC.: COMPANY SNAPSHOT
TABLE 128.ORANOXIS INC.: OPERATING SEGMENTS
TABLE 129.ORANOXIS INC.: PRODUCT PORTFOLIO
TABLE 130.ORANOXIS INC.: NET SALES
TABLE 131.ORANOXIS INC.: KEY STRATERGIES
TABLE 132.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 133.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 134.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 135.THERMO FISHER SCIENTIFIC, INC.: NET SALES
TABLE 136.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
TABLE 137.URITOX LLC.: COMPANY SNAPSHOT
TABLE 138.URITOX LLC.: OPERATING SEGMENTS
TABLE 139.URITOX LLC.: PRODUCT PORTFOLIO
TABLE 140.URITOX LLC.: NET SALES
TABLE 141.URITOX LLC.: KEY STRATERGIES
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
